# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-25-000047
Filing Date
2025-05-08
Accepted
2025-05-08 16:47:25
Documents
71
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CIDARA THERAPEUTICS, INC. FORM 10-Q | cdtx-20250331.htm iXBRL | 10-Q | 1215655
2 | EXECUTIVE OFFICERS EMPLOYMENT AGREEMENT, AS AMENDED | exhibit1042025-03.htm | EX-10.4 | 59752
3 | OPEN MARKET SALE AGREEMENT | exhibit1052025-03.htm | EX-10.5 | 285550
4 | CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 | exhibit3112025-03.htm | EX-31.1 | 10377
5 | CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 | exhibit3122025-03.htm | EX-31.2 | 10321
6 | CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 | exhibit3212025-03.htm | EX-32.1 | 7853
7 | CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 | exhibit3222025-03.htm | EX-32.2 | 7840
13 | GRAPHIC | cdtx-20250331_g1.jpg | GRAPHIC | 442393
14 | GRAPHIC | cdtx-20250331_g2.jpg | GRAPHIC | 733420
| Complete submission text file | 0001610618-25-000047.txt |  | 10120079

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cdtx-20250331.xsd | EX-101.SCH | 43904
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cdtx-20250331_cal.xml | EX-101.CAL | 65281
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cdtx-20250331_def.xml | EX-101.DEF | 299669
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cdtx-20250331_lab.xml | EX-101.LAB | 650808
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cdtx-20250331_pre.xml | EX-101.PRE | 491554
74 | EXTRACTED XBRL INSTANCE DOCUMENT | cdtx-20250331_htm.xml | XML | 739331

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 25927054
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)